Zhuhai Rundu Pharmaceutical Co Ltd Class A Net Asset Quality Index
Zhuhai Rundu Pharmaceutical Co Ltd Class A net asset quality index. Zhuhai Rundu Pharmaceutical Co Ltd Class A (002923) has a Net Asset Quality Index of 53.3% as of June 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of CN¥2.02 Billion minus total liabilities of CN¥945.74 Million yields net assets of CN¥1.08 Billion. A higher index indicates a stronger, lower-leverage balance sheet. See shareholders equity of Zhuhai Rundu Pharmaceutical Co Ltd Class for net asset value and shareholders' equity analysis.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of Zhuhai Rundu Pharmaceutical Co Ltd Class A (2011–2025)
Net asset quality index of Zhuhai Rundu Pharmaceutical Co Ltd Class A from 2011 to 2025. This chart shows how Zhuhai Rundu Pharmaceutical Co Ltd Class A's Net Asset Quality Index has evolved across 15 annual periods from 2011 to 2025. As of June 2026, the index stands at 53.3%, representing net assets of CN¥1.08 Billion against total assets of CN¥2.02 Billion CNY. Check 002923 strategic asset allocation to assess the company's strategic physical and investment asset allocation.
Zhuhai Rundu Pharmaceutical Co Ltd Class A Net Asset Quality Index by Year (2011–2025)
Zhuhai Rundu Pharmaceutical Co Ltd Class A net asset quality index by year from 2011 to 2025. The table below presents the year-by-year Net Asset Quality Index for Zhuhai Rundu Pharmaceutical Co Ltd Class A from 2011 to 2025, covering 15 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see 002923 stock market capitalisation.
| Year | Quality Index | Net Assets (CNY) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 51.2% | CN¥1.04 Billion | CN¥2.03 Billion | CN¥990.19 Million | ▼ -1.3 pp |
| 2024 | 52.5% | CN¥1.15 Billion | CN¥2.19 Billion | CN¥1.04 Billion | ▼ -0.4 pp |
| 2023 | 52.9% | CN¥1.18 Billion | CN¥2.23 Billion | CN¥1.05 Billion | ▲ +0.6 pp |
| 2022 | 52.3% | CN¥1.20 Billion | CN¥2.29 Billion | CN¥1.09 Billion | ▼ -5.9 pp |
| 2021 | 58.2% | CN¥1.11 Billion | CN¥1.91 Billion | CN¥797.28 Million | ▼ -10.3 pp |
| 2020 | 68.6% | CN¥1.04 Billion | CN¥1.51 Billion | CN¥475.54 Million | ▼ -2.3 pp |
| 2019 | 70.9% | CN¥940.29 Million | CN¥1.33 Billion | CN¥386.39 Million | ▼ -5.7 pp |
| 2018 | 76.5% | CN¥871.29 Million | CN¥1.14 Billion | CN¥267.13 Million | ▲ +7.3 pp |
| 2017 | 69.2% | CN¥488.84 Million | CN¥706.00 Million | CN¥217.16 Million | ▲ +4.7 pp |
| 2016 | 64.6% | CN¥398.19 Million | CN¥616.60 Million | CN¥218.42 Million | ▲ +2.4 pp |
| 2015 | 62.2% | CN¥310.72 Million | CN¥499.72 Million | CN¥189.00 Million | ▼ -10.6 pp |
| 2014 | 72.8% | CN¥273.31 Million | CN¥375.41 Million | CN¥102.10 Million | ▲ +4.2 pp |
| 2013 | 68.6% | CN¥236.29 Million | CN¥344.54 Million | CN¥108.25 Million | ▲ +0.8 pp |
| 2012 | 67.8% | CN¥199.43 Million | CN¥294.06 Million | CN¥94.63 Million | ▼ -1.5 pp |
| 2011 | 69.3% | CN¥165.33 Million | CN¥238.62 Million | CN¥73.29 Million | — |